Clinical Scientist (Associate Director) Experimental Medicine Early Development Oncology

Johnson & Johnson Spring House , PA 19477

Posted 2 weeks ago

Janssen Research & Development, L.L.C, a member of the Johnson & Johnson Family of Companies, is recruiting for a Clinical Scientist (Associate Director) Experimental Medicine Early Development Oncology. The preferred location for this position is Spring House, PA however Raritan, NJ or Titusville, NJ can also be an option. For the right individual, consideration can also be given to working remote. Up to 15% travel is required.

Janssen Research & Development, LLC discovers and develops innovative medical solutions to address important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Please visit for more information.

The Clinical Scientist (Associate Director) Oncology Early Development works in the Oncology Therapeutic Area Early Development (ED) group. He/she reports to a senior clinical scientist. The position will review the scope of work for central labs, central ECG and other vendors, and will oversee the study start up process including budgets and contracts, compliance with country/site regulations and SOPs.

When serving as Study Leader, this position will be responsible for the timely delivery of clinical study milestones including study starts, database locks, and topline results. Operational duties may include ensuring compliance with Good Clinical Practice guidelines and working directly with local trial managers and site monitor for smaller trials, or with the broader Global Clinical Operations group to execute early phase clinical studies.

The Clinical Scientist (Associate Director) has the following essential job functions:

  • Responsible for writing protocol synopses, full protocols, informed consent documents, and will help design Case Report Forms (CRFs) and other data collection tools.

  • He/She will work together with the Project scientist Leader to ensure the efficient initiation of early phase clinical trials and will provide input to the Statistical Analysis Plan, the Data Management Plan, and the Safety Management Plan.

  • Assist in site selection, and will lead investigator meetings and site initiation visits. For ongoing clinical trials, this individual will review all incoming clinical data in real time including patient screening results, PK/PD data, adverse events and other study endpoints and will perform medical review activities in collaboration with the SRP.

  • Scientific responsibilities will include internal activities such as interpreting clinical endpoints for topline results, preparing Clinical Study Reports, and participating in Disease Area Stronghold and Compound Development Team activities. External scientific collaborations will include interacting directly with academic investigators, coordinating clinical presentations at scientific meetings, and facilitating scientific publications in a timely manner.

  • Work within the cross-functional Early Development Clinical Team to plan, execute and oversee patient-oriented early phase clinical trials.

  • Function as the Study Leader or Co-Leader for early phase clinical trials working in close collaboration with the SRP

  • Oversee study start-up activities including site selection, study budgets, timelines, study conduct, clinical supplies, and to manage study close out activities

  • Ensure the efficient collection and review of safety, efficacy, PK/PD, and proof-of-concept data for early phase clinical trials while maintaining adherence to Good Clinical Practice (GCP) guidelines

  • Work closely with other key support areas including Global Clinical Operations, Translational Research, Medical Writing, Regulatory Affairs, Project Management, Biostatistics & Programing, and Clinical Pharmacology, and other allied support functions

  • Provide operational leadership for early trials by working directly with local site monitors and with the broader Global Clinical Operations group for larger early phase trials.

  • Provide scientific leadership internally for the conduct and interpretation of early phase trials and externally in academic collaborations and scientific presentations and publications directly related to trial outcomes


  • An advanced degree such as a Master's degree, Ph.D. or Pharm. D or with commensurate exceptional clinical research experience is required.

  • A minimum of 6 years of industry experience in Oncology drug development, early phase clinical trials, and clinical operations is required.

  • Significant knowledge of basic and translational research with an understanding of applications to cancer drug development is required.

  • The ability to work in a matrix team environment and adherence to the highest personal and ethical standards with a commitment to patient-centered clinical research are essential is required.

Johnson & Johnson Family of Companies are equal opportunity employers, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, genetic information, national origin, protected veteran status, disability status, or any other characteristic protected by law.

Primary Location

United States-Pennsylvania-Spring House-

Other Locations

North America, United States-New Jersey-Raritan, United States-New Jersey-Titusville


Janssen Research & Development, LLC. (6084)

Job Function

Clinical Research non-MD

Requisition ID

See if you are a match!

See how well your resume matches up to this job - upload your resume now.

Find your dream job anywhere
with the LiveCareer app.
Download the
LiveCareer app and find
your dream job anywhere

Boost your job search productivity with our
free Chrome Extension!

lc_apply_tool GET EXTENSION

Similar Jobs

Want to see jobs matched to your resume? Upload One Now! Remove
Scientific Director Clinical Pharmacology Oncology

Johnson & Johnson

Posted 5 days ago

VIEW JOBS 11/8/2018 12:00:00 AM 2019-02-06T00:00 The Scientific Director, Oncology Therapeutic Area (TA) Clinical Pharmacology (CP) Leader role is to apply and promote Clinical Pharmacology knowledge, including pharmacokinetics/ pharmacodynamics analyses and principles of model-based drug development in the programs for all stages of drug development ranging from pre-New Molecular Entity (NME) declaration through Post-Marketing support, in collaboration with various stakeholders, Quantitative Sciences (QS)-Project Matrix teams and Pharmacometrics (PM) Leader. The Scientific Director will function as a CP Leader on the Compound Development Team (CDT) independently and execute the day-to-day operations for the clinical pharmacology aspects of the assigned programs and mentor junior members within the Clinical Pharmacology and Pharmacometrics Department. The Scientific Director can directly impact the operational results, as they are focused on investigation and characterization of how drugs interact with biological systems or diseases so that they can be used safely and effectively, and with the appropriate pharmaceutical formulation. Contribute to overall compound development via application of quantitative methods to integrate knowledge of PK, PD, patient characteristics, disease states, and drug-drug interactions to optimize dose selection, dosage regimens and study designs throughout drug development. The Scientific Director will translate quantitative knowledge into strategic opportunities with key stake holders to drive development along the model-based drug development principles. * Collaborate with PM Leaders on modeling and simulation activities in drug development programs. Perform and/or liaise for modeling and simulation analysis of preclinical-clinical data, translational PK/PD data, up to first-in-human (FIH) and if applicable beyond FIH (dose/exposure-response analyses to guide dose regimen from pre-proof of concept (POC) and POC studies). * Collaborate with PM Leaders on the execution of scientifically robust and efficient clinical pharmacology strategies for NME and/or development candidates. * Applies the understanding of (1) the impact of intra- and inter-subject variability in physiology and/or pathology, concomitant medication use, and biopharmaceutics, on pharmacokinetics (PK) and PK/pharmacodynamics (PD), and (2) requirements for the clinical pharmacology regulatory submission packages and submission processes. * Carries out functional responsibilities in accordance to applicable SOPs, regulatory requirements and Johnson & Johnson Credo principles. Qualifications * PhD or equivalent degree in Pharmaceutical Sciences, Clinical Pharmacology, Biomedical Engineering, or relevant Biological Sciences with 8+ years of relevant experience (including postdoctoral studies) or a MS or PharmD degree or equivalent, with 10+ years of relevant experience. * Understanding of PK, PD, PK/PD, and Translational Medicine. * Ability to interpret PK and PK/PD results and prepare presentations to illustrate findings accurately. * Understanding of overall process of drug development and the overall pharmaceutical R&D process. * Has established a level of expertise and scientific reputation through publications and/or presentations. * Drug development experience in Oncology (preferred) and/or other Therapeutic Areas and the ability to handle contributions to multiple clinical pharmacology programs, simultaneously. * Demonstrated understanding of model-based drug development (MBDD), biostatistics principles and modelling tools (e.g., Gastroplus, Simcyp, Winnonlin, NONMEM) and demonstrated ability to apply these tools to enable rational and efficient drug development. * Working knowledge of clinical and regulatory landscape, disease processes and mechanisms, available treatment paradigms, and patient populations within assigned Therapeutic Area(s). Primary Location United States-Pennsylvania-Spring House- Organization Janssen Research & Development, LLC. (6084) Job Function Pharmacokinetics Requisition ID 6540181105 Johnson & Johnson Spring House PA

Clinical Scientist (Associate Director) Experimental Medicine Early Development Oncology

Johnson & Johnson